REITs invest in the majority of real estate property types, including offices, apartment buildings, warehouses, retail centers, medical facilities, data centers, cell towers and hotels.
Nareit’s REIT Directory provides a comprehensive list of REIT and publicly traded real estate companies that are members of Nareit. The directory can be sorted and filtered by sector, listing status, and stock performance.
CEM Benchmarking’s 2024 study also reveals allocations, returns, volatility, and risk-adjusted performance of 12 asset classes over 25-year period.
Partnerships are occurring across a range of REIT property sectors.
REITweek Investor Conference, taking place June 2-5 in New York, is the REIT industry’s largest annual gathering of executives, investors, and industry partners.
For 60 years, Nareit has led the U.S. REIT industry by ensuring its members’ best interests are promoted by providing unparalleled advocacy, investor outreach, continuing education and networking.
FTI Consulting's Anthony Saitta on executive compensation for commercial real estate companies.
Stifel’s John Guinee says 90%-95% of REIT balance sheets are in “excellent shape.”
Cohen & Steers’ Ji Zhang says U.S., South Korea have slight lead in 5G roll-out.
ULI’s Christopher Ptomey says COVID-19 crisis could change investor outlook on segment.
Interview with DLA Piper's Jay Epstien.
James Taiclet says 5G “going to up the game again.”
After several major M&A deals in 2018, PwC’s Tim Bodner expects “more of the same.”
Evercore’s Marty Cicco cites greater tolerance toward leverage in private market.
Size and quality of segment have “improved dramatically.”
Interview with Steadfast Income REIT President Ella Shaw Neyland
CenterSquare’s Scott Crowe says tech stocks more at risk from withdrawal of easy money policies.
CohnReznick’s Dan King says REITs well-suited to the long-term nature of opportunity zone investing.
Cornerstone's Scott Westphal on real estate fund management.
Bloomberg’s Lindsay Dutch says deal may not change competitive landscape overall.
CBRE’s Ian Anderson says the life science industry is growing at its fastest pace in 18 years.
Deloitte’s Jim Berry says it is “critical’ for firms to be agile and work with tenants to problem solve.